U S PHYSICAL THERAPY INC /NV USPH Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001140361-25-018157
cik 885978
name U S PHYSICAL THERAPY INC /NV
sic 8000
countryba US
stprba TX
cityba HOUSTON
zipba 77043
bas1 1300 WEST SAM HOUSTON PARKWAY
bas2 SUITE 300
baph 7132977000
countryma US
stprma TX
cityma HOUSTON
zipma 77043
mas1 1300 WEST SAM HOUSTON PARKWAY
mas2 SUITE 300
countryinc US
stprinc NV
ein 760364866
former
changed
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250509
accepted 2025-05-09 16:06:00.0
prevrpt 0
detail 1
instance ef20047603_10q_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001140361-25-018157 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 2799000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1731000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20241231 Assets Current 137583000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 39183000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -2179000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Change In Fair Value Of Contingent Consideration Liability 4822000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20241231 Common Stock Shares Authorized 20000000.0000 shares 0 us-gaap/2024
0001140361-25-018157 20240331 Deferred Income Tax Expense Benefit 1943000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity -175000.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20250331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 936000.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20250331 Distributions From Unconsolidated Affiliate 310000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Dividends Common Stock Cash 6836000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Fair Market Value Of Initial Contingent Consideration Related To Purchase Of Businesses 0.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Gain Loss On Sale Of Partnership 0.0000 USD 1 0001140361-25-018157 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Goodwill 586726000.0000 USD 0 us-gaap/2024 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20240331 Gross Profit 24064000.0000 USD 1 us-gaap/2024 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 17328000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Income Loss From Equity Method Investments 271000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Increase Decrease In Accounts Payable And Accrued Liabilities -6678000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Increase Decrease In Accounts Receivable 5124000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Interest Paid Net 2205000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Labor And Related Expense 12905000.0000 USD 1 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20241231 Long Term Notes Payable 903000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Minority Interest 1092000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 987000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Accrued Liabilities Current 68326000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Allowance For Doubtful Accounts Receivable Current 3620000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Clinic Closure Costs Lease And Other 127000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Clinic Closure Costs Lease And Other 242000.0000 USD 1 0001140361-25-018157 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0001140361-25-018157 20250331 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Comprehensive Income Net Of Tax 9372000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Comprehensive Income Net Of Tax 8908000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 3569000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 12943000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Depreciation And Amortization 5540000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Dividends Common Stock Cash 6836000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Furniture And Fixtures Gross 68128000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Gain Loss On Sale Of Partnership -123000.0000 USD 1 0001140361-25-018157 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20240331 Gross Profit 28401000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 1396000.0000 USD 1 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20250331 Income Taxes Paid Net 7359000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Intangible Assets Net Excluding Goodwill 177328000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Interest Expense Debt And Other 1968000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Investments In Affiliates Subsidiaries Associates And Joint Ventures 12300000.0000 USD 0 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Joint Venture Interest;
0001140361-25-018157 20250331 Liabilities 420679000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Liabilities And Stockholders Equity 1167467000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Long Term Line Of Credit 11000000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Long Term Loans Payable 128851000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Minority Interest 1700000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Net Cash Provided By Used In Financing Activities -4490000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Net Cash Provided By Used In Operating Activities 4419000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Net Income Loss 8046000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Net Income Loss 8046000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Net Income Loss 9899000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity 2012000.0000 USD 1 0001140361-25-018157 Ownership= Redeemable Non Controlling Interest;
0001140361-25-018157 20241231 Operating Lease Liability Noncurrent 101868000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Payments For Proceeds From Other Investing Activities -88000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Payments Of Dividends Minority Interest 3160000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Payments Of Dividends Minority Interest 3653000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Payments To Acquire Productive Assets 2579000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Profit Loss 11617000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Provision For Doubtful Accounts 1627000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Purchase Of Business Seller Financing Portion 500000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 260047000.0000 USD 0 us-gaap/2024 Ownership= Redeemable Non Controlling Interest;
0001140361-25-018157 20240331 Rent Supplies Contract Labor And Other 27904000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Rent Supplies Contract Labor And Other 3745000.0000 USD 1 0001140361-25-018157 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax -2903000.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax Shares 0.0000 shares 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20240331 Sale Of Non Controlling Interest Net Of Tax And Purchases 198000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Sale Of Non Controlling Interest Net Of Tax And Purchases 198000.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Share Based Compensation 1997000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Shares Outstanding 17283000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 172000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 476194000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -31628000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 481233000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 283546000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 172000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -31628000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 292773000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Stockholders Equity Other -1000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures 97000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Treasury Stock Common Shares 2215000.0000 shares 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20241231 Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity 10044000.0000 USD 4 0001140361-25-018157 Ownership= Redeemable Non Controlling Interest;
0001140361-25-018157 20250331 Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity 2012000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Notes Receivable Related To Sale Of Non Controlling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Offset To Notes Receivable Associated With Purchase Of Redeemable Non Controlling Interest 180000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Operating Income Loss 14928000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Operating Lease Liability Noncurrent 100688000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax -1781000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate 455000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Proceeds From Minority Shareholders 315000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Property Plant And Equipment Net 32140000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20231231 Redeemable Noncontrolling Interest Equity Carrying Amount 174828000.0000 USD 0 us-gaap/2024 Ownership= Redeemable Non Controlling Interest;
0001140361-25-018157 20240331 Rent Supplies Contract Labor And Other 25073000.0000 USD 1 0001140361-25-018157 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 1439000.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax -2903000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax Shares 0.0000 shares 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax Shares 0.0000 shares 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Revenue From Contract With Customer Excluding Assessed Tax 2400000.0000 USD 1 us-gaap/2024 Product Or Service= Management Contract Revenues;
0001140361-25-018157 20250331 Revenue From Contract With Customer Excluding Assessed Tax 31241000.0000 USD 1 us-gaap/2024 Product Or Service= Other Revenues Including Management Contract Revenues And Industrial Injury Prevention Services Revenues;
0001140361-25-018157 20240331 Sale Of Non Controlling Interest Net Of Tax And Purchases 198000.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20240331 Selling General And Administrative Expense 14085000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Selling General And Administrative Expense -16245000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Stockholders Equity 497261000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 477410000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -31628000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 488929000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 172000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 600000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 600000.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20231231 Treasury Stock Common Shares 2215000.0000 shares 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Weighted Average Number Of Diluted Shares Outstanding 15017000.0000 shares 1 us-gaap/2024
0001140361-25-018157 20240331 Weighted Average Number Of Shares Outstanding Basic 15017000.0000 shares 1 us-gaap/2024
0001140361-25-018157 20250331 Accounts And Other Receivables Net Current 26136000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Accrued Liabilities Current 59513000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Amortization Of Financing Costs 106000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Assets 1179687000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 41362000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -20535000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Change In Fair Value Of Contingent Consideration Liability -612000.0000 USD 1 0001140361-25-018157 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20240331 Clinic Closure Costs Lease And Other 127000.0000 USD 1 0001140361-25-018157 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Common Stock Dividends Per Share Declared 0.4500 USD 1 us-gaap/2024 Dividends= O2025 Q2 Dividends;
0001140361-25-018157 20250331 Costs And Expenses 18406000.0000 USD 1 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20250331 Deferred Income Tax Expense Benefit 5242000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20240331 Dividends Common Stock Cash 6630000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Earnings Per Share Diluted 0.4600 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Gain Loss On Revaluation Of Put Right Liability -404000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Gain Loss On Sale Of Partnership -123000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Goodwill 674387000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Gross Profit 25468000.0000 USD 1 us-gaap/2024 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 14756000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Income Loss From Equity Method Investments 400000.0000 USD 1 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Joint Venture Interest;
0001140361-25-018157 20250331 Increase Decrease In Other Operating Assets 6209000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Interest Expense Debt And Other 2279000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Interest Paid Net 1844000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Investment Income Interest 24000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Labor And Related Expense 93731000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 1060000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Minority Interest Decrease From Redemptions 383000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Minority Interest Decrease From Redemptions 345000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Net Cash Provided By Used In Financing Activities 9124000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Net Income Loss 8046000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest 3569000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 1557000.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity 89000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Notes Receivable Related To Sale Of Non Controlling Interest Permanent Equity 243000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Offset To Notes Receivable Associated With Purchase Of Redeemable Non Controlling Interest 75000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20241231 Operating Lease Liability Current 39835000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Other Assets Current 10555000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Payments To Acquire Businesses Net Of Cash Acquired 15971000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Payments To Acquire Businesses Net Of Cash Acquired 133255000.0000 USD 4 us-gaap/2024 Business Acquisition= Series Of Individually Immaterial Business Acquisitions;
0001140361-25-018157 20250331 Preferred Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates 15000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Proceeds From Lines Of Credit 0.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Profit Loss 13468000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Provision For Doubtful Accounts 1848000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Rent Supplies Contract Labor And Other 2831000.0000 USD 1 0001140361-25-018157 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Rent Supplies Contract Labor And Other 33844000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Repayments Of Long Term Debt 3750000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 1439000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20250331 Revenue From Contract With Customer Excluding Assessed Tax 152547000.0000 USD 1 us-gaap/2024 Product Or Service= Net Patient Revenues;
0001140361-25-018157 20240331 Sale Of Non Controlling Interest Net Of Tax And Purchases 0.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20231231 Shares Outstanding 17202000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 490021000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 497261000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 234161000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Stockholders Equity Other -25000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures 0.0000 shares 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20250331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 721000.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20250331 Treasury Stock Value 31628000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Weighted Average Number Of Diluted Shares Outstanding 15132000.0000 shares 1 us-gaap/2024
0001140361-25-018157 20241231 Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 87093000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1731000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1731000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Assets 232100000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20250331 Assets Current 145353000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Cash And Cash Equivalents At Carrying Value 41362000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Clinic Closure Costs Lease And Other 0.0000 USD 1 0001140361-25-018157 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0001140361-25-018157 20240331 Common Stock Dividends Per Share Declared 0.4400 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Common Stock Dividends Per Share Declared 0.4500 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Deferred Income Tax Liabilities Net 34055000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity -175000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 936000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Dividends Common Stock Cash 6630000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Gain Loss On Sale Of Property Plant Equipment -5000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Gain Loss On Sale Of Property Plant Equipment 0.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Goodwill 88106000.0000 USD 0 us-gaap/2024 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20241231 Goodwill 579046000.0000 USD 0 us-gaap/2024 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20240331 Income Loss From Equity Method Investments -271000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20240331 Income Tax Expense Benefit 3139000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Increase Decrease In Accounts Payable And Accrued Liabilities -14229000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Intangible Assets Net Excluding Goodwill 179311000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Investment Income Interest -1543000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Investments In Affiliates Subsidiaries Associates And Joint Ventures 12273000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Labor And Related Expense 79774000.0000 USD 1 us-gaap/2024 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Labor And Related Expense 111249000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Minority Interest Decrease From Redemptions 38000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20240331 Nonoperating Income Expense -172000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Operating Lease Liability Current 40124000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20240331 Other Comprehensive Income Loss Net Of Tax 1326000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Net Of Tax -991000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate -340000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Other Nonoperating Income Expense 62000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Payments To Acquire Businesses Net Of Cash Acquired 110149000.0000 USD 4 us-gaap/2024 Business Acquisition= Series Of Individually Immaterial Business Acquisitions; Business Segments= Physical Therapy Operations;
0001140361-25-018157 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0001140361-25-018157 20250331 Proceeds From Lines Of Credit 17000000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Proceeds From Minority Shareholders 646000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Proceeds From Sale Of Partnership 0.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Property Plant And Equipment Gross 122306000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Repayments Of Notes Payable 392000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 1439000.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Revenue From Contract With Customer Excluding Assessed Tax 19806000.0000 USD 1 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20240331 Sale Of Non Controlling Interest Net Of Tax And Purchases 0.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Share Based Compensation 1771000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2782000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1462000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 479771000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 290321000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1700000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Stockholders Equity Other -1000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Accounts Payable Trade Current 6088000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Accounts Receivable Net Current 59040000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1997000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 152825000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Common Stock Shares Issued 17309120.0000 shares 0 us-gaap/2024
0001140361-25-018157 20250331 Common Stock Value 172000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Depreciation And Amortization 3885000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Earnings Per Share Basic 0.4600 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Gain Loss On Revaluation Of Put Right Liability -80000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Gain Loss On Revaluation Of Put Right Liability 80000.0000 USD 1 0001140361-25-018157 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20240331 Income Loss From Equity Method Investments 300000.0000 USD 1 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Joint Venture Interest;
0001140361-25-018157 20250331 Income Loss From Equity Method Investments 393000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Income Tax Expense Benefit 3860000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Increase Decrease In Accounts Receivable And Other Operating Assets -774000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Labor And Related Expense 93574000.0000 USD 1 us-gaap/2024 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Leasehold Improvements Gross 53504000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 1060000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 987000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Minority Interest Decrease From Redemptions 345000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Net Cash Provided By Used In Investing Activities -20464000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 1344000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax 1331000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Other Liabilities Noncurrent 4903000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Other Nonoperating Income Expense 75000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Other Nonoperating Income Expense -75000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20241231 Payments To Acquire Businesses Net Of Cash Acquired 23106000.0000 USD 4 us-gaap/2024 Business Acquisition= Industrial Injury Prevention Services Business;
0001140361-25-018157 20240331 Payments To Acquire Productive Assets 1838000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Payments To Acquire Redeemable Non Controlling Interest 907000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20241231 Preferred Stock Shares Authorized 500000.0000 shares 0 us-gaap/2024
0001140361-25-018157 20250331 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0001140361-25-018157 20250331 Proceeds From Sales Of Non Controlling Interest Permanent 0.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20241231 Property Plant And Equipment Gross 119233000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Property Plant And Equipment Net 32764000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Provision For Doubtful Accounts 197000.0000 USD 1 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20241231 Redeemable Noncontrolling Interest Equity Carrying Amount 269025000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Repayments Of Notes Payable 473000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Revenue From Contract With Customer Excluding Assessed Tax 155675000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Revenue From Contract With Customer Excluding Assessed Tax 131075000.0000 USD 1 us-gaap/2024 Product Or Service= Net Patient Revenues;
0001140361-25-018157 20240331 Revenue From Contract With Customer Excluding Assessed Tax 24600000.0000 USD 1 us-gaap/2024 Product Or Service= Other Revenues Including Management Contract Revenues And Industrial Injury Prevention Services Revenues;
0001140361-25-018157 20250331 Revenue From Contract With Customer Excluding Assessed Tax 2500000.0000 USD 1 us-gaap/2024 Product Or Service= Management Contract Revenues;
0001140361-25-018157 20240331 Selling General And Administrative Expense -14085000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Selling General And Administrative Expense 16245000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 172000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 498961000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -31628000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Stockholders Equity Other 7000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Stockholders Equity Other -6000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20241231 Treasury Stock Common Shares 2214737.0000 shares 0 us-gaap/2024
0001140361-25-018157 20241231 Common Stock Value 172000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Accounts Receivable Net Current 64760000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax 1783000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Additional Paid In Capital 290321000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20241231 Allowance For Doubtful Accounts Receivable Current 3506000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Assets 1167467000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Assets 231300000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20240331 Change In Fair Value Of Contingent Consideration Liability 612000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Clinic Closure Costs Lease And Other 242000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Clinic Closure Costs Lease And Other 0.0000 USD 1 0001140361-25-018157 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20241231 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Common Stock Shares Authorized 20000000.0000 shares 0 us-gaap/2024
0001140361-25-018157 20250331 Common Stock Shares Issued 17406426.0000 shares 0 us-gaap/2024
0001140361-25-018157 20240331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 3571000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Deferred Income Tax Liabilities Net 29465000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity -175000.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Dividends Payable Current And Noncurrent 6836000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Earnings Per Share Basic 0.8000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Furniture And Fixtures Gross 68802000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Gain Loss On Revaluation Of Put Right Liability 404000.0000 USD 1 0001140361-25-018157 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20231231 Goodwill 509571000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Gross Profit 5597000.0000 USD 1 us-gaap/2024 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20240331 Income Taxes Paid Net 367000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Increase Decrease In Accounts Receivable 7341000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Increase Decrease In Other Noncurrent Liabilities -1284000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Investment Income Interest 1543000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Investments In Affiliates Subsidiaries Associates And Joint Ventures 12190000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Labor And Related Expense 13957000.0000 USD 1 us-gaap/2024 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20241231 Liabilities 408421000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Liabilities And Stockholders Equity 1179687000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Liabilities Current 116283000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Liabilities Current 123795000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Long Term Debt Current 10999000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Long Term Notes Payable 387000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Net Income Loss 9899000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest 3571000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 1557000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20250331 Nonoperating Income Expense -2314000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Operating Income Loss 19642000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20241231 Other Assets Noncurrent 5155000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Other Comprehensive Income Loss Net Of Tax 1326000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Net Of Tax -991000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20240331 Other Nonoperating Income Expense -62000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Payments To Acquire Businesses Net Of Cash Acquired 4211000.0000 USD 1 us-gaap/2024 Business Segments= Physical Therapy Operations;
0001140361-25-018157 20250331 Payments To Acquire Interest In Subsidiaries And Affiliates 0.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Provision For Doubtful Accounts 1841000.0000 USD 1 us-gaap/2024 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20241231 Retained Earnings Accumulated Deficit 227265000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Revenue From Contract With Customer Excluding Assessed Tax 183788000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Sale Of Non Controlling Interest Net Of Tax And Purchases 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Sale Of Non Controlling Interest Net Of Tax And Purchases 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20241231 Shares Outstanding 17309000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20241231 Stockholders Equity 488929000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 223772000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 227265000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1783000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Stockholders Equity Other 38000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures 81000.0000 shares 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 721000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 721000.0000 USD 1 0001140361-25-018157 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20241231 Treasury Stock Common Shares 2215000.0000 shares 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1997000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 1997000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Amortization Of Financing Costs 106000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Cash And Cash Equivalents At Carrying Value 39183000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 132290000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 12477000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Costs And Expenses 127274000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Depreciation Depletion And Amortization 4095000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Distributions From Unconsolidated Affiliate 367000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Dividends Common Stock Cash 6630000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20240331 Dividends Payable Current And Noncurrent 6630000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Earnings Per Share Diluted 0.8000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Fair Market Value Of Initial Contingent Consideration Related To Purchase Of Businesses 1259000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Gain Loss On Sale Of Partnership 0.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20241231 Goodwill 667152000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Gross Profit 31065000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Income Loss From Equity Method Investments -393000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20240331 Increase Decrease In Other Noncurrent Liabilities 52000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Investments In Affiliates Subsidiaries Associates And Joint Ventures 12200000.0000 USD 0 us-gaap/2024 Schedule Of Equity Method Investment Equity Method Investee Name= Joint Venture Interest;
0001140361-25-018157 20241231 Leasehold Improvements Gross 51105000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Liabilities 31900000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20250331 Liabilities 31400000.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20250331 Long Term Line Of Credit 28000000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Long Term Loans Payable 130627000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Net Cash Provided By Used In Operating Activities -4675000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Operating Lease Right Of Use Asset 133197000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Other Assets Current 15274000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Other Comprehensive Income Loss Net Of Tax 1326000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Payments For Proceeds From Other Investing Activities -44000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Payments To Acquire Redeemable Non Controlling Interest 2702000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20241231 Preferred Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Preferred Stock Shares Authorized 500000.0000 shares 0 us-gaap/2024
0001140361-25-018157 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0001140361-25-018157 20241231 Preferred Stock Shares Outstanding 0.0000 shares 0 us-gaap/2024
0001140361-25-018157 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates 67000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Proceeds From Sale Of Partnership 700000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Proceeds From Sales Of Non Controlling Interest Permanent 23000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20240331 Provision For Doubtful Accounts 0.0000 USD 1 us-gaap/2024 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Provision For Doubtful Accounts 7000.0000 USD 1 us-gaap/2024 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20240331 Purchase Of Redeemable Non Controlling Interest Temporary Equity Recorded In Accrued Liabilities 0.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Redeemable Noncontrolling Interest Equity Carrying Amount 260047000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Rent Supplies Contract Labor And Other 30099000.0000 USD 1 0001140361-25-018157 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Retained Earnings Accumulated Deficit 234161000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Sale Of Non Controlling Interest Net Of Tax And Purchases 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Shares Outstanding 17406000.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4108000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 223573000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2799000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20250331 Stockholders Equity Other -31000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20240331 Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures 0.0000 shares 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20250331 Treasury Stock Common Shares 2214737.0000 shares 0 us-gaap/2024
0001140361-25-018157 20250331 Weighted Average Number Of Shares Outstanding Basic 15132000.0000 shares 1 us-gaap/2024
0001140361-25-018157 20241231 Accounts And Other Receivables Net Current 26626000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20241231 Accounts Payable Trade Current 5936000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 89542000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Additional Paid In Capital 292773000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Change In Fair Value Of Contingent Consideration Liability -4822000.0000 USD 1 0001140361-25-018157 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Costs And Expenses 152723000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20250331 Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 936000.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20250331 Depreciation Depletion And Amortization 5867000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Dividends Common Stock Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Dividends Common Stock Cash 6836000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0001140361-25-018157 20250331 Goodwill 87661000.0000 USD 0 us-gaap/2024 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20240331 Gross Profit 4337000.0000 USD 1 us-gaap/2024 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Gross Profit 1400000.0000 USD 1 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20240331 Increase Decrease In Accounts Receivable And Other Operating Assets 3985000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Increase Decrease In Other Operating Assets 433000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Interest Expense Debt And Other -1968000.0000 USD 1 0001140361-25-018157 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Interest Expense Debt And Other -2279000.0000 USD 1 0001140361-25-018157 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Investment Income Interest -24000.0000 USD 1 us-gaap/2024 Consolidation Items= Corporate Non Segment;
0001140361-25-018157 20250331 Labor And Related Expense 17675000.0000 USD 1 us-gaap/2024 Business Segments= Industrial Injury Prevention Services Revenues; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Long Term Debt Current 9257000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Minority Interest Decrease From Distributions To Noncontrolling Interest Holders 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Minority Interest Decrease From Redemptions 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Net Cash Provided By Used In Investing Activities -6628000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Net Income Loss 9899000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Common Stock;
0001140361-25-018157 20250331 Net Income Loss 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 1344000.0000 USD 1 0001140361-25-018157 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0.0000 USD 1 0001140361-25-018157 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity 2227000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Nonoperating Income Expense -4000.0000 USD 1 us-gaap/2024 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20241231 Operating Lease Right Of Use Asset 133936000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Other Assets Noncurrent 4385000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20250331 Other Comprehensive Income Loss Net Of Tax -991000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20241231 Other Liabilities Noncurrent 18275000.0000 USD 0 us-gaap/2024
0001140361-25-018157 20250331 Payments To Acquire Businesses Net Of Cash Acquired 4211000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Payments To Acquire Interest In Subsidiaries And Affiliates 498000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Provision For Doubtful Accounts 1627000.0000 USD 1 us-gaap/2024 Business Segments= Physical Therapy Operations; Consolidation Items= Operating Segments;
0001140361-25-018157 20250331 Purchase Of Business Seller Financing Portion 0.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20250331 Purchase Of Redeemable Non Controlling Interest Temporary Equity Recorded In Accrued Liabilities 6672000.0000 USD 1 0001140361-25-018157
0001140361-25-018157 20241231 Redeemable Noncontrolling Interest Equity Carrying Amount 269025000.0000 USD 0 us-gaap/2024 Ownership= Redeemable Non Controlling Interest;
0001140361-25-018157 20250331 Rent Supplies Contract Labor And Other 5304000.0000 USD 1 0001140361-25-018157 Consolidated Entities= Variable Interest Entity Primary Beneficiary;
0001140361-25-018157 20240331 Repayments Of Long Term Debt 938000.0000 USD 1 us-gaap/2024
0001140361-25-018157 20240331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax -2903000.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20250331 Revaluation Of Redeemable Non Controlling Interest Net Of Tax Shares 0.0000 shares 1 0001140361-25-018157 Equity Components= Common Stock;
0001140361-25-018157 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 281096000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1216000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1092000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0001140361-25-018157 20240331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Stockholders Equity Other 0.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001140361-25-018157 20240331 Stockholders Equity Other -1000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 0.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20240331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Accumulated Other Comprehensive Income;
0001140361-25-018157 20240331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 600000.0000 USD 1 0001140361-25-018157 Equity Components= Parent;
0001140361-25-018157 20250331 Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0.0000 USD 1 0001140361-25-018157 Equity Components= Retained Earnings;
0001140361-25-018157 20240331 Treasury Stock Common Shares 2215000.0000 shares 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001140361-25-018157 20241231 Treasury Stock Value 31628000.0000 USD 0 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Increase Decrease In Accounts Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Operating Lease Liability Current us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Current Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Fair Market Value Of Initial Contingent Consideration Related To Purchase Of Businesses 0001140361-25-018157 1 0 monetary D D Fair Market Value of Initial Contingent Consideration Related to Purchase of Businesses Fair market value of initial contingent consideration related to purchase of businesses.
Depreciation And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization, Nonproduction The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
Minority Interest Decrease From Redemptions us-gaap/2024 0 0 monetary D D Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).
Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2024 0 0 monetary D C Payments to Acquire Businesses, Net of Cash Acquired The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.
Proceeds From Minority Shareholders us-gaap/2024 0 0 monetary D D Proceeds from Noncontrolling Interests Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment us-gaap/2024 0 0 monetary I C Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
Allowance For Doubtful Accounts Receivable Current us-gaap/2024 0 0 monetary I C Accounts Receivable, Allowance for Credit Loss, Current Amount of allowance for credit loss on accounts receivable, classified as current.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Long Term Loans Payable us-gaap/2024 0 0 monetary I C Loans Payable, Noncurrent Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax us-gaap/2024 0 0 monetary D D Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.
Payments Of Dividends Minority Interest us-gaap/2024 0 0 monetary D C Payments of Ordinary Dividends, Noncontrolling Interest Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.
Payments To Acquire Productive Assets us-gaap/2024 0 0 monetary D C Payments to Acquire Productive Assets The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Clinic Closure Costs Lease And Other 0001140361-25-018157 1 0 monetary D D Clinic Closure Costs Lease and Other Amount of expense related to closure costs incurred for clinic closure, lease and other.
Accounts Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Dividends Per Share Declared us-gaap/2024 0 0 perShare D Common Stock, Dividends, Per Share, Declared Aggregate dividends declared during the period for each share of common stock outstanding.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Investments In Affiliates Subsidiaries Associates And Joint Ventures us-gaap/2024 0 0 monetary I D Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Amount of investment in equity method investee and investment in and advance to affiliate.
Long Term Notes Payable us-gaap/2024 0 0 monetary I C Notes Payable, Noncurrent Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stockholders Equity Other us-gaap/2024 0 0 monetary D D Stockholders' Equity, Other This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.
Treasury Stock Value us-gaap/2024 0 0 monetary I D Treasury Stock, Value The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Distributions From Unconsolidated Affiliate 0001140361-25-018157 1 0 monetary D D Distributions from Unconsolidated Affiliate The cash inflow associated with the distributions from unconsolidated affiliate.
Offset To Notes Receivable Associated With Purchase Of Redeemable Non Controlling Interest 0001140361-25-018157 1 0 monetary D D Offset to Notes Receivable Associated with Purchase of Redeemable Non-Controlling Interest The amount of offset to notes receivable associated with purchase of redeemable non-controlling interest.
Sale Of Non Controlling Interest Net Of Tax And Purchases 0001140361-25-018157 1 0 monetary D C Sale of non-controlling interest, net of tax and purchases Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest or decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Dividends Common Stock Cash us-gaap/2024 0 0 monetary D D Dividends, Common Stock, Cash Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.
Dividends Payable Current And Noncurrent us-gaap/2024 0 0 monetary I C Dividends Payable Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Furniture And Fixtures Gross us-gaap/2024 0 0 monetary I D Furniture and Fixtures, Gross Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Payments For Proceeds From Other Investing Activities us-gaap/2024 0 0 monetary D C Payments for (Proceeds from) Other Investing Activities Amount of cash (inflow) outflow from investing activities classified as other.
Payments To Acquire Interest In Subsidiaries And Affiliates us-gaap/2024 0 0 monetary D C Payments to Acquire Interest in Subsidiaries and Affiliates The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).
Revaluation Of Redeemable Non Controlling Interest Net Of Tax Shares 0001140361-25-018157 1 0 shares D Revaluation of Redeemable Non-controlling Interest Net of Tax, Shares Number of shares issued during the period related to redeemable non-controlling interest.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Increase Decrease In Other Operating Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Operating Assets Amount of increase (decrease) in operating assets classified as other.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Repayments Of Long Term Debt us-gaap/2024 0 0 monetary D C Repayments of Long-Term Debt The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
Selling General And Administrative Expense us-gaap/2024 0 0 monetary D D Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures us-gaap/2024 0 0 shares D Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.
Accounts And Other Receivables Net Current us-gaap/2024 0 0 monetary I D Accounts and Other Receivables, Net, Current Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.
Accounts Payable Trade Current us-gaap/2024 0 0 monetary I C Accounts Payable, Trade, Current Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Accounts Receivable And Other Operating Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts Receivable and Other Operating Assets Amount of increase (decrease) in receivables, and operating assets classified as other.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Long Term Line Of Credit us-gaap/2024 0 0 monetary I C Long-Term Line of Credit, Noncurrent The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders us-gaap/2024 0 0 monetary D D Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.
Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Nonoperating Income (Expense) The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Purchase Of Business Seller Financing Portion 0001140361-25-018157 1 0 monetary D C Purchase of Business Seller Financing Portion Purchase of business - seller financing portion in noncash investing or financing activities.
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Costs And Expenses us-gaap/2024 0 0 monetary D D Costs and Expenses Total costs of sales and operating expenses for the period.
Deferred Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Goodwill us-gaap/2024 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Leasehold Improvements Gross us-gaap/2024 0 0 monetary I D Leasehold Improvements, Gross Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Assets Current us-gaap/2024 0 0 monetary I D Other Assets, Current Amount of current assets classified as other.
Other Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Repayments Of Notes Payable us-gaap/2024 0 0 monetary D C Repayments of Notes Payable The cash outflow for a borrowing supported by a written promise to pay an obligation.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Proceeds From Sale Of Partnership 0001140361-25-018157 1 0 monetary D D Proceeds from sale of partnership The proceeds from the sale of partnership.
Proceeds From Sales Of Non Controlling Interest Permanent 0001140361-25-018157 1 0 monetary D D Proceeds from Sales of Non-controlling Interest Permanent The cash inflow associated with the sales of non-controlling interest-permanent.
Amortization Of Financing Costs us-gaap/2024 0 0 monetary D D Amortization of Debt Issuance Costs Amount of amortization expense attributable to debt issuance costs.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Redeemable Noncontrolling Interest Equity Carrying Amount us-gaap/2024 0 0 monetary I C Redeemable Noncontrolling Interest, Equity, Carrying Amount As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
Gain Loss On Sale Of Partnership 0001140361-25-018157 1 0 monetary D C Gain (Loss) on Sale of Partnership Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend.
Interest Expense Debt And Other 0001140361-25-018157 1 0 monetary D D Interest Expense, Debt and Other Expense Debt related expenses and other expenses associated with nonoperating financing activities of the entity.
Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0001140361-25-018157 1 0 monetary D C Revaluation of Redeemable Non-controlling Interest Net of Tax Amount of distributions during the period on mandatorily redeemable securities net of tax.
Deferred Income Tax Liabilities Net us-gaap/2024 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Labor And Related Expense us-gaap/2024 0 0 monetary D D Labor and Related Expense Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates us-gaap/2024 0 0 monetary D D Proceeds from Divestiture of Interest in Subsidiaries and Affiliates The cash inflow associated with the deconsolidation of a previously consolidated subsidiary or sale of an entity that is related to it but not strictly controlled.
Proceeds From Lines Of Credit us-gaap/2024 0 0 monetary D D Proceeds from Lines of Credit Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
Property Plant And Equipment Gross us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Gross Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Shares Outstanding us-gaap/2024 0 0 shares I Shares, Outstanding Number of shares issued which are neither cancelled nor held in the treasury.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0001140361-25-018157 1 0 monetary D D Deferred Taxes Related to Redeemable Non-controlling Interest Temporary Equity The amount of deferred taxes related to redeemable non-controlling interest temporary equity.
Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity 0001140361-25-018157 1 0 monetary D D Net Income Loss Attributable To Redeemable Noncontrolling Interest temporary Equity Amount of Net Income (Loss) attributable to redeemable noncontrolling interest temporary equity.
Notes Receivable Related To Sale Of Non Controlling Interest Permanent Equity 0001140361-25-018157 1 0 monetary D D Notes Receivable Related to sale of Non-Controlling Interest, Permanent Equity Amount of cash inflow from a noncontrolling interest. Includes, permanent equity.
Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate 0001140361-25-018157 1 0 monetary D D Other Comprehensive Income (Loss), Tax Expense (Benefit) at Federal and State Statutory Income Tax Rate The amount of income tax expense (OCI) or benefit for the period computed by applying the domestic federal and state statutory tax rates to pretax income.
Payments To Acquire Redeemable Non Controlling Interest 0001140361-25-018157 1 0 monetary D C Payments to Acquire Redeemable Non-controlling Interest The cash outflow associated with the acquisition of a redeemable non-controlling interest.
Rent Supplies Contract Labor And Other 0001140361-25-018157 1 0 monetary D D Rent Supplies Contract Labor and Other Amount of expense related to rent, supplies, contract labor and other.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
Investment Income Interest us-gaap/2024 0 0 monetary D C Investment Income, Interest Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Preferred Stock Shares Outstanding us-gaap/2024 0 0 shares I Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Noncurrent Liabilities Amount of increase (decrease) in noncurrent operating liabilities classified as other.
Gain Loss On Revaluation Of Put Right Liability 0001140361-25-018157 1 0 monetary D C Gain (loss) on revaluation of put-right liability Gain (loss) on revaluation of put-right liability.
Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0001140361-25-018157 1 0 monetary D D Net Income Loss Attributable To Noncontrolling Interest, Permanent Equity Amount of Net Income (Loss) attributable to noncontrolling interest permanent equity.
Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity 0001140361-25-018157 1 0 monetary D C Notes Payable Related to Purchase of Redeemable Non-controlling Interest, Temporary Equity The amount of business acquisition cost of acquired entity debt issued (temporary equity) on the date of acquisition.
Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0001140361-25-018157 1 0 monetary D C Transfer of Compensation Liability for Certain Stock Issued Pursuant to Incentive Plans Refers to transfer of compensation liability for certain stock issued pursuant to incentive plans.
Long Term Debt Current us-gaap/2024 0 0 monetary I C Long-Term Debt, Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.
Minority Interest us-gaap/2024 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Provision For Doubtful Accounts us-gaap/2024 0 0 monetary D D Accounts Receivable, Credit Loss Expense (Reversal) Amount of expense (reversal of expense) for expected credit loss on accounts receivable.
Treasury Stock Common Shares us-gaap/2024 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Change In Fair Value Of Contingent Consideration Liability 0001140361-25-018157 1 0 monetary D C Change in Fair Value of Contingent Consideration, Liability Amount of change in fair value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.
Purchase Of Redeemable Non Controlling Interest Temporary Equity Recorded In Accrued Liabilities 0001140361-25-018157 1 0 monetary D C Purchase of redeemable non-controlling interest, temporary equity, recorded in accrued liabilities The cash outflow associated with the acquisition of a redeemable non-controlling interest.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001140361-25-018157 2 16 BS 0 H Goodwill us-gaap/2024 Goodwill 0
0001140361-25-018157 2 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001140361-25-018157 2 4 BS 0 H Accounts Receivable Net Current us-gaap/2024 Patient accounts receivable, less provision for credit losses of $3,620 and $3,506, respectively 0
0001140361-25-018157 2 5 BS 0 H Accounts And Other Receivables Net Current us-gaap/2024 Accounts receivable - other 0
0001140361-25-018157 2 6 BS 0 H Other Assets Current us-gaap/2024 Other current assets 0
0001140361-25-018157 2 7 BS 0 H Assets Current us-gaap/2024 Total current assets 0
0001140361-25-018157 2 9 BS 0 H Furniture And Fixtures Gross us-gaap/2024 Furniture and equipment 0
0001140361-25-018157 2 10 BS 0 H Leasehold Improvements Gross us-gaap/2024 Leasehold improvements 0
0001140361-25-018157 2 11 BS 0 H Property Plant And Equipment Gross us-gaap/2024 Fixed assets, gross 0
0001140361-25-018157 2 12 BS 0 H Accumulated Depreciation Depletion And Amortization Property Plant And Equipment us-gaap/2024 Less accumulated depreciation and amortization 1
0001140361-25-018157 2 13 BS 0 H Property Plant And Equipment Net us-gaap/2024 Fixed assets, net 0
0001140361-25-018157 2 14 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use assets 0
0001140361-25-018157 2 15 BS 0 H Investments In Affiliates Subsidiaries Associates And Joint Ventures us-gaap/2024 Investment in unconsolidated affiliate 0
0001140361-25-018157 2 17 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 Other identifiable intangible assets, net 0
0001140361-25-018157 2 18 BS 0 H Other Assets Noncurrent us-gaap/2024 Other assets 0
0001140361-25-018157 2 19 BS 0 H Assets us-gaap/2024 Total assets 0
0001140361-25-018157 2 22 BS 0 H Accounts Payable Trade Current us-gaap/2024 Accounts payable - trade 0
0001140361-25-018157 2 23 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued expenses 0
0001140361-25-018157 2 24 BS 0 H Operating Lease Liability Current us-gaap/2024 Current portion of operating lease liabilities 0
0001140361-25-018157 2 25 BS 0 H Long Term Debt Current us-gaap/2024 Current portion of term loan and notes payable 0
0001140361-25-018157 2 26 BS 0 H Liabilities Current us-gaap/2024 Total current liabilities 0
0001140361-25-018157 2 27 BS 0 H Long Term Notes Payable us-gaap/2024 Notes payable, net of current portion 0
0001140361-25-018157 2 28 BS 0 H Long Term Line Of Credit us-gaap/2024 Revolving facility 0
0001140361-25-018157 2 29 BS 0 H Long Term Loans Payable us-gaap/2024 Term loan, net of current portion and deferred financing costs 0
0001140361-25-018157 2 30 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred taxes 0
0001140361-25-018157 2 31 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liabilities, net of current portion 0
0001140361-25-018157 2 32 BS 0 H Other Liabilities Noncurrent us-gaap/2024 Other long-term liabilities 0
0001140361-25-018157 2 33 BS 0 H Liabilities us-gaap/2024 Total liabilities 0
0001140361-25-018157 2 34 BS 0 H Redeemable Noncontrolling Interest Equity Carrying Amount us-gaap/2024 Redeemable non-controlling interest - temporary equity 0
0001140361-25-018157 2 35 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and Contingencies 0
0001140361-25-018157 2 37 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding 0
0001140361-25-018157 2 38 BS 0 H Common Stock Value us-gaap/2024 Common stock, $.01 par value, 20,000,000 shares authorized, 17,406,426 and 17,309,120 shares issued, respectively 0
0001140361-25-018157 2 39 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001140361-25-018157 2 40 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive gain 0
0001140361-25-018157 2 41 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Retained earnings 0
0001140361-25-018157 2 42 BS 0 H Treasury Stock Value us-gaap/2024 Treasury stock at cost, 2,214,737 shares 1
0001140361-25-018157 2 43 BS 0 H Stockholders Equity us-gaap/2024 Total USPH shareholders' equity 0
0001140361-25-018157 2 44 BS 0 H Minority Interest us-gaap/2024 Non-controlling interest - permanent equity 0
0001140361-25-018157 2 45 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total USPH shareholders' equity and non-controlling interest - permanent equity 0
0001140361-25-018157 2 46 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total liabilities, redeemable non-controlling interest, USPH shareholders' equity and non-controlling interest - permanent equity 0
0001140361-25-018157 3 3 BS 1 H Allowance For Doubtful Accounts Receivable Current us-gaap/2024 Provision for credit losses, patient accounts receivable 0
0001140361-25-018157 3 6 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value (in dollars per share) 0
0001140361-25-018157 3 7 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized (in shares) 0
0001140361-25-018157 3 8 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued (in shares) 0
0001140361-25-018157 3 9 BS 1 H Preferred Stock Shares Outstanding us-gaap/2024 Preferred stock, shares outstanding (in shares) 0
0001140361-25-018157 3 10 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0001140361-25-018157 3 11 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized (in shares) 0
0001140361-25-018157 3 12 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued (in shares) 0
0001140361-25-018157 3 13 BS 1 H Treasury Stock Common Shares us-gaap/2024 Treasury stock (in shares) 0
0001140361-25-018157 4 8 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Net revenue 0
0001140361-25-018157 4 10 IS 0 H Labor And Related Expense us-gaap/2024 Salaries and related costs 0
0001140361-25-018157 4 11 IS 0 H Rent Supplies Contract Labor And Other 0001140361-25-018157 Rent, supplies, contract labor and other 0
0001140361-25-018157 4 12 IS 0 H Depreciation And Amortization us-gaap/2024 Depreciation and amortization 0
0001140361-25-018157 4 13 IS 0 H Provision For Doubtful Accounts us-gaap/2024 Provision for credit losses 0
0001140361-25-018157 4 14 IS 0 H Clinic Closure Costs Lease And Other 0001140361-25-018157 Clinic closure costs - lease and other 0
0001140361-25-018157 4 15 IS 0 H Costs And Expenses us-gaap/2024 Total operating cost 0
0001140361-25-018157 4 16 IS 0 H Gross Profit us-gaap/2024 Gross profit 0
0001140361-25-018157 4 17 IS 0 H Selling General And Administrative Expense us-gaap/2024 Corporate office costs 0
0001140361-25-018157 4 18 IS 0 H Change In Fair Value Of Contingent Consideration Liability 0001140361-25-018157 Gain on change in fair value of contingent earn-out consideration 1
0001140361-25-018157 4 19 IS 0 H Operating Income Loss us-gaap/2024 Operating income 0
0001140361-25-018157 4 21 IS 0 H Interest Expense Debt And Other 0001140361-25-018157 Interest expense, debt and other 1
0001140361-25-018157 4 22 IS 0 H Investment Income Interest us-gaap/2024 Interest income from investments 0
0001140361-25-018157 4 23 IS 0 H Gain Loss On Revaluation Of Put Right Liability 0001140361-25-018157 Change in revaluation of put-right liability 0
0001140361-25-018157 4 24 IS 0 H Income Loss From Equity Method Investments us-gaap/2024 Equity in earnings of unconsolidated affiliate 0
0001140361-25-018157 4 25 IS 0 H Gain Loss On Sale Of Partnership 0001140361-25-018157 Loss on sale of a partnership 0
0001140361-25-018157 4 26 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other 0
0001140361-25-018157 4 27 IS 0 H Nonoperating Income Expense us-gaap/2024 Total other expense 0
0001140361-25-018157 4 28 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Income before taxes 0
0001140361-25-018157 4 29 IS 0 H Income Tax Expense Benefit us-gaap/2024 Provision for income taxes 0
0001140361-25-018157 4 30 IS 0 H Profit Loss us-gaap/2024 Net income 0
0001140361-25-018157 4 32 IS 0 H Net Income Loss Attributable To Redeemable Noncontrolling Interest Temporary Equity 0001140361-25-018157 Redeemable non-controlling interest - temporary equity 1
0001140361-25-018157 4 33 IS 0 H Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0001140361-25-018157 Non-controlling interest - permanent equity 1
0001140361-25-018157 4 34 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 Net income attributable to non-controlling interest 1
0001140361-25-018157 4 35 IS 0 H Net Income Loss us-gaap/2024 Net income attributable to USPH shareholders 0
0001140361-25-018157 4 36 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic earnings per share attributable to USPH shareholders (in dollars per share) 0
0001140361-25-018157 4 37 IS 0 H Earnings Per Share Diluted us-gaap/2024 Diluted earnings per share attributable to USPH shareholders (in dollars per share) 0
0001140361-25-018157 4 38 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Shares used in computation - basic (in shares) 0
0001140361-25-018157 4 39 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Shares used in computation - diluted (in shares) 0
0001140361-25-018157 4 40 IS 0 H Common Stock Dividends Per Share Declared us-gaap/2024 Dividends declared per common share (in dollars per share) 0
0001140361-25-018157 5 1 CI 0 H Profit Loss us-gaap/2024 Net income 0
0001140361-25-018157 5 3 CI 0 H Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax us-gaap/2024 Unrealized (loss) gain on cash flow hedge 1
0001140361-25-018157 5 4 CI 0 H Other Comprehensive Income Loss Tax Expense Benefit At Federal And State Statutory Income Tax Rate 0001140361-25-018157 Tax effect at statutory rate (federal and state) 1
0001140361-25-018157 5 5 CI 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Comprehensive income 0
0001140361-25-018157 5 6 CI 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 Comprehensive income attributable to non-controlling interest 1
0001140361-25-018157 5 7 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive income attributable to USPH shareholders 0
0001140361-25-018157 6 2 CF 0 H Profit Loss us-gaap/2024 Net income including non-controlling interest 0
0001140361-25-018157 6 4 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001140361-25-018157 6 5 CF 0 H Provision For Doubtful Accounts us-gaap/2024 Provision for credit losses 0
0001140361-25-018157 6 6 CF 0 H Share Based Compensation us-gaap/2024 Equity-based awards compensation expense 0
0001140361-25-018157 6 7 CF 0 H Amortization Of Financing Costs us-gaap/2024 Amortization of debt issue costs 0
0001140361-25-018157 6 8 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2024 Change in deferred income taxes 0
0001140361-25-018157 6 9 CF 0 H Gain Loss On Revaluation Of Put Right Liability 0001140361-25-018157 Change in revaluation of put-right liability 1
0001140361-25-018157 6 10 CF 0 H Change In Fair Value Of Contingent Consideration Liability 0001140361-25-018157 Gain on change in fair value of contingent earn-out consideration 1
0001140361-25-018157 6 11 CF 0 H Income Loss From Equity Method Investments us-gaap/2024 Equity of earnings in unconsolidated affiliate 1
0001140361-25-018157 6 12 CF 0 H Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 Loss on sale of fixed assets 1
0001140361-25-018157 6 13 CF 0 H Gain Loss On Sale Of Partnership 0001140361-25-018157 Loss on sale of a partnership 1
0001140361-25-018157 6 15 CF 0 H Increase Decrease In Accounts Receivable us-gaap/2024 Increase in patient accounts receivable 1
0001140361-25-018157 6 16 CF 0 H Increase Decrease In Accounts Receivable And Other Operating Assets us-gaap/2024 Decrease (increase) in accounts receivable - other 1
0001140361-25-018157 6 17 CF 0 H Increase Decrease In Other Operating Assets us-gaap/2024 Increase in other current and long term assets 1
0001140361-25-018157 6 18 CF 0 H Increase Decrease In Accounts Payable And Accrued Liabilities us-gaap/2024 Decrease in accounts payable and accrued expenses 0
0001140361-25-018157 6 19 CF 0 H Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 (Decrease) increase in long term liabilities 0
0001140361-25-018157 6 20 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash (used in) provided by operating activities 0
0001140361-25-018157 6 22 CF 0 H Payments To Acquire Productive Assets us-gaap/2024 Purchase of fixed assets 1
0001140361-25-018157 6 23 CF 0 H Payments To Acquire Businesses Net Of Cash Acquired us-gaap/2024 Purchase of majority interest in businesses, net of cash acquired 1
0001140361-25-018157 6 24 CF 0 H Payments To Acquire Redeemable Non Controlling Interest 0001140361-25-018157 Purchase of redeemable non-controlling interest, temporary equity 1
0001140361-25-018157 6 25 CF 0 H Payments To Acquire Interest In Subsidiaries And Affiliates us-gaap/2024 Purchase of non controlling interest, permanent equity 1
0001140361-25-018157 6 26 CF 0 H Proceeds From Divestiture Of Interest In Subsidiaries And Affiliates us-gaap/2024 Proceeds from the sale of partnership interest - redeemable non-controlling interest, temporary equity 0
0001140361-25-018157 6 27 CF 0 H Proceeds From Sales Of Non Controlling Interest Permanent 0001140361-25-018157 Proceeds from the sale of non-controlling interest, permanent equity 0
0001140361-25-018157 6 28 CF 0 H Proceeds From Sale Of Partnership 0001140361-25-018157 Proceeds from sale of partnership 0
0001140361-25-018157 6 29 CF 0 H Distributions From Unconsolidated Affiliate 0001140361-25-018157 Distributions from unconsolidated affiliate 0
0001140361-25-018157 6 30 CF 0 H Payments For Proceeds From Other Investing Activities us-gaap/2024 Other 1
0001140361-25-018157 6 31 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash (used in) investing activities 0
0001140361-25-018157 6 33 CF 0 H Proceeds From Lines Of Credit us-gaap/2024 Proceeds from revolving facility 0
0001140361-25-018157 6 34 CF 0 H Payments Of Dividends Minority Interest us-gaap/2024 Distributions to non-controlling interest, permanent and temporary equity 1
0001140361-25-018157 6 35 CF 0 H Repayments Of Long Term Debt us-gaap/2024 Payments on term loan 1
0001140361-25-018157 6 36 CF 0 H Repayments Of Notes Payable us-gaap/2024 Principal payments on notes payable 1
0001140361-25-018157 6 37 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by (used in) financing activities 0
0001140361-25-018157 6 38 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net (decrease) in cash and cash equivalents 0
0001140361-25-018157 6 39 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents - beginning of period 0
0001140361-25-018157 6 40 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents - end of period 0
0001140361-25-018157 6 43 CF 0 H Income Taxes Paid Net us-gaap/2024 Income taxes 0
0001140361-25-018157 6 44 CF 0 H Interest Paid Net us-gaap/2024 Interest paid 0
0001140361-25-018157 6 46 CF 0 H Purchase Of Business Seller Financing Portion 0001140361-25-018157 Purchase of businesses - seller financing portion 0
0001140361-25-018157 6 47 CF 0 H Purchase Of Redeemable Non Controlling Interest Temporary Equity Recorded In Accrued Liabilities 0001140361-25-018157 Purchase of redeemable non-controlling interest, temporary equity, recorded in accrued liabilities 0
0001140361-25-018157 6 48 CF 0 H Fair Market Value Of Initial Contingent Consideration Related To Purchase Of Businesses 0001140361-25-018157 Fair market value of initial contingent consideration related to purchase of businesses 0
0001140361-25-018157 6 49 CF 0 H Notes Payable Related To Purchase Of Redeemable Non Controlling Interest Temporary Equity 0001140361-25-018157 Notes payable related to purchase of redeemable non-controlling interest, temporary equity 0
0001140361-25-018157 6 50 CF 0 H Proceeds From Minority Shareholders us-gaap/2024 Notes receivable related to sale of redeemable non-controlling interest 0
0001140361-25-018157 6 51 CF 0 H Notes Receivable Related To Sale Of Non Controlling Interest Permanent Equity 0001140361-25-018157 Notes receivable related to the sale of non-controlling interest, permanent equity 0
0001140361-25-018157 6 52 CF 0 H Offset To Notes Receivable Associated With Purchase Of Redeemable Non Controlling Interest 0001140361-25-018157 Offset to notes receivable associated with purchase of redeemable non-controlling interest 0
0001140361-25-018157 6 53 CF 0 H Dividends Payable Current And Noncurrent us-gaap/2024 Dividends payable to USPH shareholders 0
0001140361-25-018157 7 13 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Beginning balance 0
0001140361-25-018157 7 14 EQ 0 H Shares Outstanding us-gaap/2024 Beginning balance (in shares) 0
0001140361-25-018157 7 15 EQ 0 H Treasury Stock Common Shares us-gaap/2024 Beginning balance (in shares) 1
0001140361-25-018157 7 16 EQ 0 H Net Income Loss us-gaap/2024 Net income attributable to USPH shareholders 0
0001140361-25-018157 7 17 EQ 0 H Net Income Loss Attributable To Noncontrolling Interest Permanent Equity 0001140361-25-018157 Net income attributable to non-controlling interest - permanent equity 0
0001140361-25-018157 7 18 EQ 0 H Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures us-gaap/2024 Issuance of restricted stock, pursuant to the secondary offering, net of cancellations 0
0001140361-25-018157 7 19 EQ 0 H Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures us-gaap/2024 Issuance of restricted stock, pursuant to the secondary offering, net of cancellations (in shares) 0
0001140361-25-018157 7 20 EQ 0 H Revaluation Of Redeemable Non Controlling Interest Net Of Tax 0001140361-25-018157 Revaluation of redeemable non-controlling interest 1
0001140361-25-018157 7 21 EQ 0 H Revaluation Of Redeemable Non Controlling Interest Net Of Tax Shares 0001140361-25-018157 Revaluation of redeemable non-controlling interest (in shares) 0
0001140361-25-018157 7 22 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Compensation expense - equity-based awards 0
0001140361-25-018157 7 23 EQ 0 H Sale Of Non Controlling Interest Net Of Tax And Purchases 0001140361-25-018157 Sale of non-controlling interest 0
0001140361-25-018157 7 24 EQ 0 H Minority Interest Decrease From Redemptions us-gaap/2024 Purchase of partnership interests - non-controlling interest 1
0001140361-25-018157 7 25 EQ 0 H Dividends Common Stock Cash us-gaap/2024 Dividends payable to USPH shareholders 1
0001140361-25-018157 7 26 EQ 0 H Minority Interest Decrease From Distributions To Noncontrolling Interest Holders us-gaap/2024 Distributions to non-controlling interest partners - permanent equity 1
0001140361-25-018157 7 27 EQ 0 H Deferred Taxes Related To Redeemable Non Controlling Interest Temporary Equity 0001140361-25-018157 Deferred taxes related to redeemable non-controlling interest - temporary equity 0
0001140361-25-018157 7 28 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive gain 0
0001140361-25-018157 7 29 EQ 0 H Transfer Of Compensation Liability For Certain Stock Issued Pursuant To Incentive Plans 0001140361-25-018157 Transfer of compensation liability for certain stock issued pursuant to long-term incentive plans 0
0001140361-25-018157 7 30 EQ 0 H Stockholders Equity Other us-gaap/2024 Other 0
0001140361-25-018157 7 31 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Ending balance 0
0001140361-25-018157 7 32 EQ 0 H Shares Outstanding us-gaap/2024 Ending balance (in shares) 0
0001140361-25-018157 7 33 EQ 0 H Treasury Stock Common Shares us-gaap/2024 Ending balance (in shares) 1

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.